323 related articles for article (PubMed ID: 33450859)
21. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cell-derived exosomes decrease Hyperplasia in Psoriasis by inducing transforming growth factor β2 (TGF-β2).
Abed ZI; Arianejad M; Azizi Z
Mol Biol Rep; 2024 May; 51(1):635. PubMed ID: 38727850
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
Al-Harbi NO; Nadeem A; Ahmad SF; Bakheet SA; El-Sherbeeny AM; Ibrahim KE; Alzahrani KS; Al-Harbi MM; Mahmood HM; Alqahtani F; Attia SM; Alotaibi MR
Eur J Pharmacol; 2020 Jun; 877():173088. PubMed ID: 32234429
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis.
Alves CO; Novaes RD; Bernardes MTCP; Gonçalves RV; da Silva LP; Agostini SBN; Pereira GR; Carvalho FC
J Pharm Pharmacol; 2022 Sep; 74(9):1342-1352. PubMed ID: 35355075
[TBL] [Abstract][Full Text] [Related]
25. IL-23- and Imiquimod-Induced Models of Experimental Psoriasis in Mice.
Singh TP; Zhang HH; Hwang ST; Farber JM
Curr Protoc Immunol; 2019 Jun; 125(1):e71. PubMed ID: 30615272
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
Pohin M; Guesdon W; Mekouo AA; Rabeony H; Paris I; Atanassov H; Favot L; Mcheik J; Bernard FX; Richards CD; Amiaud J; Blanchard F; Lecron JC; Morel F; Jégou JF
Eur J Immunol; 2016 Jul; 46(7):1737-51. PubMed ID: 27122058
[TBL] [Abstract][Full Text] [Related]
27. 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaT cells.
Kwon TR; Lee SE; Kim JH; Na Jang Y; Kim SY; Mun SK; Kim CW; Na J; Kim BJ
Photochem Photobiol Sci; 2020 Aug; 19(8):1009-1021. PubMed ID: 32584352
[TBL] [Abstract][Full Text] [Related]
28. An Assessment of Administration Route on MSC-sEV Therapeutic Efficacy.
Zhang B; Lai RC; Sim WK; Tan TT; Lim SK
Biomolecules; 2024 May; 14(6):. PubMed ID: 38927026
[TBL] [Abstract][Full Text] [Related]
29. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
30. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration.
Ha DH; Kim HK; Lee J; Kwon HH; Park GH; Yang SH; Jung JY; Choi H; Lee JH; Sung S; Yi YW; Cho BS
Cells; 2020 May; 9(5):. PubMed ID: 32392899
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous absorption of resveratrol and its oligomers to relieve psoriasiform lesions: In silico, in vitro and in vivo evaluations.
Cheng CY; Lin YK; Yang SC; Alalaiwe A; Lin CJ; Fang JY; Lin CF
Int J Pharm; 2020 Jul; 585():119507. PubMed ID: 32512223
[TBL] [Abstract][Full Text] [Related]
33. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
34. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
35. Thymol activates TRPM8-mediated Ca
Wang W; Wang H; Zhao Z; Huang X; Xiong H; Mei Z
Toxicol Appl Pharmacol; 2020 Nov; 407():115247. PubMed ID: 32971067
[TBL] [Abstract][Full Text] [Related]
36. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
37. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk.
Shao S; Fang H; Dang E; Xue K; Zhang J; Li B; Qiao H; Cao T; Zhuang Y; Shen S; Zhang T; Qiao P; Li C; Gudjonsson JE; Wang G
Front Immunol; 2019; 10():746. PubMed ID: 31024570
[TBL] [Abstract][Full Text] [Related]
39. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.
Smith SH; Peredo CE; Takeda Y; Bui T; Neil J; Rickard D; Millerman E; Therrien JP; Nicodeme E; Brusq JM; Birault V; Viviani F; Hofland H; Jetten AM; Cote-Sierra J
PLoS One; 2016; 11(2):e0147979. PubMed ID: 26870941
[TBL] [Abstract][Full Text] [Related]
40. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
